Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: Cancer. 2021 Apr 7;127(14):2515–2524. doi: 10.1002/cncr.33473

TABLE 2.

Timeline of Care by Race/Ethnicity, Pathologic Diagnosis, Age, and Funding Among Patients With Breast Pathology, North Carolina Breast and Cervical Cancer Control Program, 2008–2018

Time to Diagnosis, Median (IQR), d P Time to Treatment, Median (IQR), d P Time From Imaging to Treatment, Median (IQR), d P Time From Diagnosis to Treatment, Median (IQR), d P
Race/ethnicity .54 .23 .09 .13
 Asian/Pacific Islander 13 (6–40) 30 (11–57) 31 (14–45) 7 (0–18)
 Hispanic 20 (10–35) 34 (19–60) 25 (12–44) 8 (2–21)
 American Indian 15 (12–27) 36 (24–49) 29 (17–41) 21 (4–31)
 Non-Hispanic Black 20 (10–36) 35 (19–57) 28 (14–48) 10 (2–21)
 Non-Hispanic White 19 (10–31) 31 (19–49) 25 (14–41) 8 (0–19)
 Unknown 22 (17–33) 28 (23–60) 27 (14–49) 11 (2–21)
Pathologic diagnosis .68 .98 .66 .45
 Atypia 18 (12–37) 34 (16–57) 28 (14–47) 9 (0–19)
 Malignancy 20 (10–33) 33 (19–54) 26 (14–44) 8 (1–21)
Age <.001 <.001 <.001 .14
 <50 y 18 (8–30) 30 (17–48) 24 (12–40) 8 (0–19)
 ≥50 y 21 (11–36) 35 (20–58) 28 (15–48) 9 (2–21)
Funding <.001 <.001 <.001 .001
 Fully funded 21 (12–36) 35 (20–57) 26 (13–43) 8 (0–21)
 Partially funded 19 (10–32) 34 (20–52) 29 (19–48) 12 (3–21)
 Not funded 12 (5–22) 22 (12–38) 18 (10–34) 7 (2–15)

Abbreviation: IQR, interquartile range.